Form 4: Clover Health Executive Sells $345k in Class A Stock

Brady Priest, CEO of Clover Care Services, disposed of 98,039 shares of Clover Health Investments, Corp. at a price of $3.52 per share.

Summary

• Brady Patrick Priest, CEO of Clover Care Services, sold 98,039 shares of Class A Common Stock on May 13, 2026.
• The shares were sold at a price of $3.52 per share, totaling approximately $345,097.28 in gross proceeds.
• Following this transaction, the reporting person still directly owns 2,040,222 shares of the company.
• The transaction was filed as a standard Statement of Changes in Beneficial Ownership (Form 4).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as slightly negative due to the nature of insider selling, but the impact is mitigated by the executive's significant remaining equity stake.

Positives

• The reporting person retains a substantial ownership stake of over 2 million shares, indicating continued alignment with shareholder interests.
• The sale represents only approximately 4.6% of the executive's total direct holdings.

Negatives

• Insider selling can be interpreted by the market as a lack of confidence in immediate share price appreciation.
• The sale occurred at a price point of $3.52, which may set a psychological resistance level for some investors.

Risks

• No specific business risks were disclosed in this transaction-focused filing.

Future Outlook

The filing does not provide forward-looking guidance or strategic outlook statements.

Management Comments

• No specific comments or statements were provided by management in this regulatory filing.

Industry Context

StockSavvy.ai notes that insider sales in the health insurance and technology space are frequently used for personal liquidity or tax planning. Compared to larger peers like UnitedHealth or Humana, Clover Health's executive transactions are often scrutinized more closely due to the company's growth-stage volatility.

Comparison to Industry Standards

• The sale volume is relatively low compared to major institutional block trades seen in the S&P 500 healthcare sector.
• Executive retention of over 95% of their position following a sale is generally viewed more favorably than 'exit-style' liquidations seen in some tech startups.

Related Party Transactions

• The reported transaction is a sale of equity by a primary officer of the company.

Stakeholder Impact

• Shareholders may experience minor negative sentiment due to insider selling activity.
• No direct impact on customers, employees, or creditors is expected from this individual stock sale.

Next Steps

• Monitor for additional Form 4 filings from other executives to determine if this is a coordinated selling effort.
• Await the next quarterly earnings report to assess if the sale preceded any changes in operational performance.

Key Dates

Recommendation

A single insider sale representing a small fraction of total holdings is rarely a sufficient catalyst for a rating change. Investors should maintain current positions while monitoring broader company performance.

Keywords

Clover Health, CLOV, Insider Selling, Brady Priest, Class A Common Stock, Healthcare Technology, SEC Form 4